Cargando…
Vagus nerve stimulation as adjunctive therapy in patients with difficult-to-treat depression (RESTORE-LIFE): study protocol design and rationale of a real-world post-market study
BACKGROUND: Depressive illness is associated with significant adverse consequences for patients and their families, and for society. Clinical challenges are encountered in the management of patients suffering from depression whether they are designated difficult-to-treat or treatment-resistant. Pros...
Autores principales: | Young, Allan H., Juruena, Mario F., De Zwaef, Renske, Demyttenaere, Koen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526425/ https://www.ncbi.nlm.nih.gov/pubmed/32993573 http://dx.doi.org/10.1186/s12888-020-02869-6 |
Ejemplares similares
-
Vagus nerve stimulation therapy in people with drug-resistant epilepsy (CORE-VNS): rationale and design of a real-world post-market comprehensive outcomes registry
por: Sen, Arjune, et al.
Publicado: (2021) -
Vagus nerve stimulation: An evolving adjunctive treatment for cardiac disease
por: Akdemir, Barış, et al.
Publicado: (2016) -
Vagus Nerve Stimulation: A Potential Adjunct Therapy for COVID-19
por: Azabou, Eric, et al.
Publicado: (2021) -
Safety and tolerability of adjunct non-invasive vagus nerve stimulation in people with parkinson’s: a study protocol
por: Sigurdsson, Hilmar P., et al.
Publicado: (2023) -
Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression
por: Kumar, Arun, et al.
Publicado: (2019)